Modeling of the major gas vesicle protein, GvpA: from protein sequence to vesicle wall structure

Journal of Structural Biology
Hussein M EzzeldinSantiago D Solares

Abstract

The structure and assembly process of gas vesicles have received significant attention in recent decades, although relatively little is still known. This work combines state-of-the-art computational methods to develop a model for the major gas vesicle protein, GvpA, and explore its structure within the assembled vesicle. Elucidating this protein's structure has been challenging due to its adherent and aggregative nature, which has so far precluded in-depth biochemical analyses. Moreover, GvpA has extremely low similarity with any known protein structure, which renders homology modeling methods ineffective. Thus, alternate approaches were used to model its tertiary structure. Starting with the sequence from haloarchaeon Halobacterium sp. NRC-1, we performed ab initio modeling and threading to acquire a multitude of structure decoys, which were equilibrated and ranked using molecular dynamics and mechanics, respectively. The highest ranked predictions exhibited an α-β-β-α secondary structure in agreement with earlier experimental findings, as well as with our own secondary structure predictions. Afterwards, GvpA subunits were docked in a quasi-periodic arrangement to investigate the assembly of the vesicle wall and to conduct sim...Continue Reading

References

Aug 5, 1976·Journal of Molecular Biology·A E Blaurock, A E Walsby
Jan 1, 1992·Archives of Microbiology·P K HayesA E Walsby
Jun 1, 1992·Journal of General Microbiology·A E GriffithsP K Hayes
Jul 5, 1990·Journal of Molecular Biology·D G KnellerR Langridge
Mar 1, 1970·Journal of Molecular Biology·S B Needleman, C D Wunsch
Feb 14, 1971·Journal of Molecular Biology·B Lee, F M Richards
Nov 1, 1995·Proteins·A SaliM Karplus
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Jun 5, 1998·Microbiology·Sonja OffnerFelicitas Pfeifer
Oct 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·W V NgS DasSarma
Apr 12, 2001·Current Opinion in Structural Biology·T A Halgren, W Damm
May 17, 2001·Extremophiles : Life Under Extreme Conditions·R Margesin, F Schinner
Jun 14, 2001·Journal of Biotechnology·E S StuartS DasSarma
Sep 7, 2002·Journal of Molecular Biology·Richard BonneauDavid Baker
Dec 26, 2003·Biophysical Journal·Marina BelenkyJudith Herzfeld
Sep 15, 2004·Journal of Molecular Graphics & Modelling·Benjamin J Carrington, Ricardo L Mancera
Dec 9, 2004·Bioinformatics·Gianluca Pollastri, Aoife McLysaght
Jun 9, 2005·Current Opinion in Structural Biology·John Moult
Jun 28, 2005·Nucleic Acids Research·Kevin BrysonDavid T Jones
Jun 28, 2005·Nucleic Acids Research·J ChengP Baldi
Sep 28, 2005·Proteins·James J VincentByungkook Lee
Oct 14, 2005·Journal of Computational Chemistry·James C PhillipsKlaus Schulten
Dec 20, 2005·Biophysical Journal·Matthias BuckAlexander D MacKerell
Jan 28, 2006·Analytical and Bioanalytical Chemistry·Nathaniel G Portney, Mihrimah Ozkan
Feb 13, 2007·The Journal of Physical Chemistry. B·Santiago D Solares
Jan 25, 2008·BMC Bioinformatics·Yang Zhang
May 9, 2008·Nucleic Acids Research·Christian ColeGeoffrey J Barton
Feb 24, 2009·Journal of Molecular Biology·Astrid C SivertsenJudith Herzfeld
Aug 21, 2009·Expert Opinion on Drug Delivery·James B DelehantyIgor L Medintz
Sep 24, 2009·Proteins·Moshe Ben-DavidYaakov Levy
Oct 20, 2009·Trends in Pharmacological Sciences·Yogeshkumar MalamAlexander M Seifalian
Dec 17, 2009·BMC Bioinformatics·Christiam CamachoThomas L Madden
Sep 23, 2010·Biophysical Journal·Astrid C SivertsenJudith Herzfeld
Jan 5, 2011·Saline Systems·Satyajit L DassarmaShiladitya Dassarma
May 6, 2011·Molecular Microbiology·Timo StrunkFelicitas Pfeifer

❮ Previous
Next ❯

Citations

Sep 10, 2015·Vaccines·Shiladitya DasSarma, Priya DasSarma
Feb 5, 2015·Life·Felicitas Pfeifer
Sep 5, 2015·Theoretical Biology & Medical Modelling·Bee Yin KhorYee Siew Choong
Mar 27, 2018·Annual Review of Chemical and Biomolecular Engineering·David MarescaMikhail G Shapiro
Jun 26, 2015·The Journal of Biological Chemistry·Morten S DueholmPer Halkjær Nielsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.